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Abstract
A major mechanism regulating the accessibility and function of eukaryotic genomes are the
covalent modifications to DNA and histone proteins that dependably package our genetic
information inside the nucleus of every cell. Formally postulated over a decade ago, it is becoming
increasingly clear that post-translational modifications (PTMs) on histones act singly and in
combination to form a language or ‘code’ that is read by specialized proteins to facilitate
downstream functions in chromatin. Underappreciated at the time was the level of complexity
harbored both within histone PTMs and their combinations, as well as within the proteins that read
and interpret the language. In addition to histone PTMs, newly-identified DNA modifications that
can recruit specific effector proteins has raised further awareness that histone PTMs operate within
a broader language of epigenetic modifications to orchestrate the dynamic functions associated
with chromatin. Here, we highlight key recent advances in our understanding of the epigenetic
language encompassing histone and DNA modifications and foreshadow challenges that lie ahead
as we continue our quest to decipher the fundamental mechanisms of chromatin regulation.
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1. Introduction
1.1. Chromatin balances DNA packaging and accessibility
Eukaryotic DNA is tightly packaged within the nucleus of each cell and must be faithfully
regulated, copied, and transmitted during cell division. DNA packaging amounts to an
amazing feat, often requiring several meters of DNA to be compacted into the confines of a
2–10 micron nucleus. This high level of compaction presents a potential problem, as the
underlying DNA must remain accessible to the vast protein machineries that utilize it for
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critical biological functions. Thus, a fundamental question being addressed by many labs has
been how these diverse genomic functions, such as gene transcription, DNA repair,
replication, and recombination, occur at the appropriate place and time to promote cellular
growth, differentiation, and proper organismal development.
Key contributors to DNA packaging are the highly basic histone proteins, which wrap ~147
base pairs of DNA around an octamer of histones (2 copies each of H3, H4, H2A and H2B)
to form thenucleosome core particle [1, 2]. This repeating nucleosomal subunit is the
fundamental building block of chromatin. Chromatin is organized into distinct domains,
such as euchromatin and heterochromatin, which are defined by the level of compaction and
associated genomic functions. For example, euchromatin has relatively loose compaction
and is typically transcriptionally permissive, whereas heterochromatin (facultative or
constitutive) is more condensed and typically transcriptionally repressive [3–5]. The degree
to which chromatin is organized and packaged is highly influenced by numerous factors,
including the actions of linker histone H1 that regulates the formation of higher-order
chromatin states [6], histone variants that can be substituted for canonical histones in the
nucleosome core particle [7], chromatin remodelers that use the power of ATP hydrolysis to
slide and evict histones [8], histone chaperones that facilitate deposition and eviction of
histones [9, 10], and small chemical modifications to histones and DNA [11–15], whose
interwoven functions are the primary focus of this review.
1.2. Histone PTMs and the ‘histone code’:a rich and vibrant new language has emerged
A major mechanism by which chromatin structure and function is regulated is through the
actions of histone post-translational modifications (PTMs). An astonishing number of
PTMs, including lysine acetylation, lysine and arginine methylation, arginine citrullination,
lysine ubiquitination, lysine sumoylation, ADP-ribosylation, proline isomerization, and
serine/threonine/tyrosine phosphorylation occur on histones [11, 15] (Table 1). While the
majority are found in the flexible N- and C-terminal ‘tail’ domains that protrude away from
the nucleosome core particle, a significant number also occur in the histone fold or globular
domains that regulate histone-histone and histone-DNA interactions [16, 17].
A long-standing question in the field has been how histone PTMs function in chromatin
regulation. While it has been half a century since Vincent Allfrey first described the
presence of acetylation and methylation on histones [18], and Lubomir Hnilica documented
histone phosphorylation [19], the functional significance of these modifications remained
elusive for many years. Fundamental breakthroughs in our understanding of histone PTM
function (many of which occurred in recent years) have been made through the identification
of the protein machineries that incorporate (write), remove (erase), and bind (read) histone
PTMs. Two landmark discoveries in this regard were the identifications in 1996 of p55/
Gcn5 and HDAC1/Rpd3 as transcription-associated histone acetyltransferases[20]and
deacetylases[21], respectively – thereby linking dynamic histone modification activity
directly to the transcription process. These findings changed the landscape of how the
transcription and chromatin fields viewed histone PTMs and have resulted in a fast-paced
and exciting field that shows no signs of slowing down.
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In 2000, the concept of a‘histone code’ emerged as a hypothesis to stimulate new thinking
about how histone PTMs might function [22, 23]. This postulate grew out of the observation
that histone H3 serine 10 (H3S10) phosphorylation could be associated with seemingly
opposite functions in chromatin (i.e., chromatin decompaction in transcription and
chromatin condensation in mitosis) [24–28]. From analysis of this and other PTMs where
the associated functions were known, it was possible to infer that PTMs might work singly
as well as in combination (on one or more histone tails) to mediate the distinct functions
associated with them. It was envisioned that, in addition to histone PTMs having a direct
physical effect on chromatin structure (as is the case for lysine acetylation negating the
positive charge of this residue) [29], they might also function through the selective
recruitment of effector proteins or readers that ‘dock’ onto histone PTMs to direct specific
downstream events in chromatin. One of the major landmarks in deciphering this aspect of
the hypothesis was the discovery of the bromodomain module as an acetyl-lysine reader
motif [30]. This result paved the way for subsequent characterization of this important
family of chromatin effectors [31, 32], and further suggested the existence of other, yet-to-
be identified protein domains, that read histone PTMs.
A large body of data now supports the notion that histone PTMs function, at least in part,
through the recruitment of effector proteins harboring specialized reader domains [33, 34].
While the ‘histone code’ hypothesis provided a retrospectively simplistic explanation of how
histone PTMs function, recent advances have revealed that the context in which histone
PTMs operate is much more complex than originally envisioned. In addition to
combinatorial PTMs that function together both synergistically and antagonistically, there is
now an appreciation for PTM asymmetry within individual nucleosomes [35], novel types of
PTMs with unique functions [36], nucleosomes bearing histone variants [7], and nuclear
compartmentalization events [5] that are all contributing to the final output of chromatin
organization and function. Furthermore, fueled in part by the recent discovery of an active
DNA demethylation pathway and proteins that read these pathway intermediates [14, 37], a
new appreciation for the function of histone PTMs in coordination with DNA modifications
is emerging. This review will focus on several key findings from the last few years that have
helped to expand our current understanding of how histone PTMs and DNA modifications
function in the context of a more integrated epigenetic language [22, 38]. Posing several key
questions to the field, we also foreshadow where studies into chromatin organization and
function are headed and highlight several new technologies that are taking us there.
2. Increasing complexity of the histone PTM landscape
2.1. Identifying and mapping histone PTMs beyond the histone tails
Technological advances in mass spectrometric (MS)-based analyses of histones have greatly
facilitated our understanding of the types of PTMs that occur on histones, as well as their
abundance and co-occurrence [39–43]. Perhaps one of the most surprising findings from
early MS studies using the high resolving power of Fourier transform ion cyclotron
resonance MS was the significant number of previously unknown acetylation, methylation
and phosphorylation events that were detected on the N- and C-terminal tail domains as well
as on the globular regions of histones [44]. From this analysis and additional studies [16,
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45–47], a vast and mostly unexplored PTM landscape emerged that has greatly expanded the
potential complexity of the histone modification language (Table 1). Underappreciated at the
time of our original postulate was the potential for a significant number of PTMs to occur
along or near the histone-DNA interface where the histone octamer contacts wrapped DNA
– thus providing an additional means by which nucleosome stability and/or DNA
interactions on the surface can be regulated [16]. Histone-DNA interface PTMs (in contrast
to those located on the histone tail domains) largely act in a physical manner by tweaking or
fine-tuning histone-DNA interactions that in turn affect nucleosome stability and/or
mobility. Evidence for this effect came from elegant in vitro studies employing semi-
synthetic or genetically modified nucleosomes to show that histone fold acetylation at
H3K56, H3K155 and H3K122, in addition to phosphorylation of H3T118, resulted in
weakened histone-DNA interactions, increased nucleosome mobility, and DNA unwrapping
[48–53]. Significantly, H3K122 was recently identified as a substrate for the p300/CBP
histone acetyltransferase [54]. H3K122ac was found to be enriched at gene promoters and is
required for proper transcriptional activation, but how p300/CBP targets H3K122, which is
in a largely inaccessible and buried region in the nucleosome core particle, is not yet
understood.
While PTMs located at the histone-DNA interface regulate the intrinsic properties of the
nucleosome core particle, it is noteworthy that these modifications can also regulate effector
protein association similar to those located in the tail domains. For example, JAK2-mediated
phosphorylation of H3Y41, a site located at the DNA entry/exit point [55], was found to be
refractory to HP1α chromatin association by perturbing an interaction between the HP1α
chromoshadow domain and H3 in this region. While H3Y41 was shown to relieve HP1-
mediated gene repression, it remains to be determined whether H3Y41 phosphorylation
negates HP1α interaction in the context of H3K9me3 [56, 57]. Interestingly, neighboring
H3R42 was recently identified as a substrate for CARM1 and PRMT6-mediated asymmetric
dimethylation (H3R42me2a) [58]. H3R42me2a was linked to active transcription in vitro,
suggesting this PTM alters chromatin structure by removing a potential hydrogen bond
donor contributing to histone-DNA interaction. It is intriguing to also speculate that
H3R42me2a may elicit positive transcriptional effects in the cell by negating HP1 binding.
2.2. An expanding dictionary of histone PTMs
Along with the identification of new PTM sites on histones, recent MS analyses have also
focused on the identification of novel types of histone PTMs. From these studies, a
surprising number of newly-identified modifications have been uncovered (Table 1),
including lysine crotonylation, lysine butyrylation, lysine propionylation, lysine
succinylation,lysine malonylation (all of which are derived from distinct co-enzyme A
molecules), lysine 5-hydroxylation, lysine N-formylation, tyrosine hydroxylation, serine/
threonine/tyrosine acetylation, and serine/threonine O-GlcNAcylation (for an in depth
review, see [36]). It is important note that a number of these above-mentioned PTMs are low
in abundance as compared to more well-studied modifications, suggesting their roles in
physical and functional cross-talk may be discreet. While the functions of these newly
described PTMs are largely awaiting discovery, exciting recent studies are revealing that
they can play key roles in genome function. Several examples are highlighted below.
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Lysine crotonylation is a highly conserved PTM that is causally linked to gene activation
and nucleosome disruption [59]. Crotonylation is a four-carbon moiety, and (like lysine
acetylation) neutralizes the positive charge of this residue. Using pan-lysine crotonylation-
specific antibodies that detect each core histone in addition to H1, this novel modification
was shown to be enriched at gene promoters, predicted enhancers, and transcriptionally
active X/Y sex-linked genes that escape repression in male post-meiotic spermatids [59–61].
While these studies suggest a role for lysine crotonylation in active transcription, it remains
unclear which specific crotonylated lysine residues are linked to the observations above.
Future work will therefore be needed to identify all of the residues in histones that harbor
this mark, and how each mark may contribute to gene regulation or other functions
associated with DNA. It is noteworthy that histone acetyltransferases capable of utilizing
butyryl-CoA and propionyl-CoA are unable to utilize the crotonyl-CoA cofactor due to its
flattened, extended, and more rigid carbon-carbon π-bond[59]. Thus, it will be exciting to
identify the class of histone-modifying enzymes that write and erase this PTM.
Intriguingly, two sites of lysine crotonylation have recently been identified to occur at
H3K122 (a site also found to be acetylated, see above) and H4K77 [62]. These lysines lie
near the dyad axis on opposite sides of the nucleosome, and thus, are in a position to directly
regulate histone-DNA interactions and nucleosome stability. This study found that defective
incorporation of the H2B variant TH2B, normally required for the disruption and
replacement of histones with protamines during spermatogenesis, resulted in increased
lysine crotonylation (in addition to increased arginine methylation) in the histone fold
domains of H4 and H2B. This appears to be a compensatory mechanism for not having
TH2B present.
Another example where significant insight has been revealed for a novel histone PTM is
with the serine/threonine sugar modification O-linked β-N-acetylglucosamine (O-GlcNAc).
Studies have found that O-GlcNAc transferase (OGT) and the hydrolase O-GlcNAcase
(OGA) are the enzymes that write and erase this PTM, both on histones and non-histone
proteins [63–66]. The nucleotide sugar donor used by OGT (UDP-GlcNAc)is highly
regulated by nutrient levels and is rate limiting in the cell [67, 68]. Studies therefore suggest
O-GlcNAcis a sensor of nutrient status, controlling gene expression programs in response to
changing nutrient conditions and environmental stress. In C. elegans, OGT has been mapped
to gene promoters that are connected to metabolism, growth, aging, and the stress response,
and is important for the proper transcriptional regulation of these genes [69]. In Drosophila,
OGT has been identified as the protein product of the super sex combs (sxc) gene, a member
of the polycomb group (PcG) proteins required for the PcG-mediated repression of
developmentally regulated genes [70, 71]. Given O-GlcNAcylation is intimately associated
with nutrient sensing and metabolism, this finding suggests that there is a nutrient
responsive and/or metabolic component to PcG repression and organismal development.
Important to note, however, is that O-GlcNAcylation is well known to occur on non-histone
proteins involved in transcription (e.g., MLL5, polymerase II (RNAPII), and the PcG factor
Polyhomeotic) [70, 72–74]. Therefore, it will be important to resolve whether O-
GlcNAcylation that occurs on histones is indeed contributing to the gene regulation
programs identified above.
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In mammals, O-GlcNAcylation is a modification that occurs on each of the core histones
and is regulated in a cell cycle-dependent manner [75]. Peak levels of O-GlcNAc occur
during G1 and drop in S-phase, followed by a rise occurring through G2 and M phase. O-
GlcNAc was found to occur at H3S10, posing an interesting question as to whether O-
GlcNAcylation is functionally antagonistic with H3S10 phosphorylation. Since O-GlcNAc
levels are highest in G1, it is plausible that H3S10 O-GlcNAcylation acts as a molecular
‘switch’ to negatively regulate gene expression normally controlled by H3S10
phosphorylation. Intriguingly, O-GlcNAc has also been found to crosstalk with other histone
PTMs, notably H2BK120 monoubiquitination [76]. Specifically, O-GlcNAcylation of
H2BS112 in Drosophila was found to promote H2BK120Ub1 through the recruitment of the
ubiquitination machinery [76]. These studies indicate a positive role for O-GlcNAcylation in
transcription. In agreement with this notion, it was shown that OGT recruitment by the DNA
methylcytosine dioxygenase TET2 (see section 3.3) facilitates H2BS112 O-GlcNAcylation
during gene reactivation [77]. As OGT was found to be required with TET2 for gene
reactivation, the study suggests that DNA methylcytosine oxidation is coordinated with
other histone marks to facilitate reactivation of TET2-regulated genes. This serves as an
important example of how our understanding of histone PTM function has evolved over the
years to encompass an intimate DNA component (a topic discussed in detail below).
The studies described above have provided important insights into the function of newly
discovered PTMs that occur on histones – yet fundamental questions remain about the role
of these and other aforementioned PTMs in chromatin regulation. For example, what are the
writers, erasers, and potential readers of these modifications? In the case of lysine
butyrylation and propionylation, which use distinct co-enzyme A cofactors (butyryl-CoA
and propionyl-CoA), studies have shown that they can be catalyzed and removed by histone
acetyltransferases and deacetylases [78, 79]. Given that these different Co-A forms are
created by distinct metabolic pathways, and thus can be regulated by metabolic flux, it may
be that these distinct lysine modification forms play specialized roles in fine-tuning gene
expression programs in response to nutrient imbalance.Significantly, this principle of
metabolic flux regulating epigenetic signatures is a fundamental aspect of chromatin
regulation, recently reviewed in detail elsewhere [80, 81].
It is also intriguing to speculate that, like lysine acetylation, distinct Co-A forms are read by
bromodomain-containing proteins. Indeed, structures of the first bromodomain of Brd4
solved in complex with proprionylated H3K23 and butyrylated H3K14 demonstrate that
these moieties are coordinated similarly to acetyllysine [82]. For these and other newly
identified PTMs, it will be important to determine where they occur across the genome, how
they show crosstalk with other PTMs, and what functions are mediated downstream of these
modifications. Given what has been discovered so far with lysine crotonylation and O-
GlcNAcylation, it is likely that these other novel modifications will also have important and
exciting roles in chromatin function.
2.3. PTM combinations and asymmetry add increasing diversity to histone function
In addition to expanded mapping of individual histone PTMs, the co-existence of histone
modifications has gained new appreciation based on recent studiesemploying high resolution
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tandem MS and improved MS approaches to detect the short and long-range histone PTM
combinations that occur. These studies, examining the N-termini of H31–50 and H41–23,
have identified a staggering number of diversely modified H3.2 and H4 N-terminal forms (>
200 each for H3.2 and H4) in mammalian histones [40, 83, 84]. The H3 N-terminus was
found to be the most highly modified histone N-terminus compared to the other core
histones, and can contain up to 7 PTM combinations in a single N-terminal fragment. These
studies also confirm several previously observed findings, including the co-occurrence of
H3K4 methylation with neighboring acetylation [85, 86]. Given that the C-terminal regions
of histones have not been examined to this same extent, along with the inclusion of
phosphorylation events that were not readily observed from the asynchronous cells used in
the above studies (but would exist during mitosis), there appears be an astonishing number
of potential PTM combinations that add diversity to the histone language. Key to our
understanding of how histone PTMs function is to elucidate how the readers, writers, and
erasers behave in this combinatorial context. Along these lines, a number of high-throughput
technologies, including peptide microarray-based screening approaches, have recently been
employed to begin characterizing these complex interactions and substrate specificities [87–
92].
While much progress has been made in identifying the co-occurrence and mutual exclusivity
of histone PTM combinations, it has been technically challenging to determine whether
polypeptides within a histone homodimer are modified in the same way. Further challenges
have been faced in determining whether identified combinations occur along the same
histone polypeptide (symmetrically) or on adjacent polypeptides within a histone
homodimer (asymmetrically). Major advances in our understanding of histone PTM
patterning within a single nucleosome came from a recent study by Reinberg, Garcia, and
colleagues [35]. Histone PTM-specific antibodies were used to enrich for mononucleosomes
bearing a PTM of interest, and the abundance of these marks was quantified following
tryptic digestion using liquid chromatography-coupled MS (LC/MS). Assuming the histone
PTM antibody was specific and did not enrich for mononucleosomes lacking the mark of
interest (a key assumption for accurate interpretation of these data) [93], the relative
abundance of unmodified vs. modified histone peptide in the MS pool provided insight into
the degree of symmetry of a specific PTM. Applying this approach to H3K27me2 and
H3K27me3 (marks of facultative heterochromatin written by the EZH2 subunit of the PRC2
complex [94]) as well as H4K20me1 (written by PR-Set7 and involved in the DNA damage
response and mitotic chromatin condensation [95]), populations of symmetrically and
asymmetrically modified nucleosomes were identified. These experiments provided the first
evidence that histone H3 and H4 homodimers are not necessarily modified identically within
a single nucleosome.
A potentially important role for asymmetry has now been realized in the context of
development. Genome-wide mapping studies have documented the co-occurrence of
H3K4me3 (associated with active transcription) and H3K27me3 (a dominant mark of
transcriptional repression) at developmental gene promoters in embryonic stem cells
(defined as ‘bivalency’) [96] – the notion being that these two marks might reside on the
same H3 tail to transcriptionally ‘poise’ these loci for rapid transcriptional activation in
response to cellular cues leading to demethylation of H3K27me3. Surprisingly, high-
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resolution MS studies found that these marks do not co-exist on the same H3 tail [83]. This
seemingly opposing result was clarified by the finding that H3K4me3 and H3K27me3 exist
within a single nucleosome, but occur on adjacent histones within a homodimer [35].
Consistent with this observation, it has been demonstrated that PRC2 cannot methylate
H3K27 when H3K4me3 is present on the same tail [35, 97].
The identification of asymmetrically modified nucleosomes greatly increases our awareness
for how histone PTMs operate. It will be important to extend these studies to other histone
modifications to determine the degree of symmetry and asymmetry across the spectrum of
histone PTM combinations. Furthermore, the enzymology and biochemistry directing
symmetric and asymmetric PTM combinations will surely be exciting new avenues of
discovery. Given our recent appreciation for the ability of histone effector proteins to sense
PTMs on adjacent histone tails (see below and Fig. 1), it is intriguing to also speculate that
the functional outcomes of symmetric and asymmetric PTM combinations may be distinct.
2.4. Multivalency in histone PTM recognition
Much of our understanding of histone PTM function has come from the identification that
unique folds or domains within chromatin-associated proteins can ‘read’ histone PTMs and
their combinations to drive distinct functions in chromatin, a central tenet in the original
‘histone code’ postulate. A structurally diverse family of histone reader domains has been
discovered over the last decade, including bromodomains that bind acetyllysine,
chromodomains that bind methyllysine, plant homeodomain (PHD) fingers that bind
acetyllysine, methyllysine, and even unmodified lysine, Tudor domains that bind
methyllysine and methylarginine, and BRCT domains that bind phosphoserine (Table 1).
Recent comprehensive reviews detail the structural properties of these and other identified
histone reader domains and highlight the diverse biochemical implications of their
interactions [33, 34].
It has become increasingly apparent that many chromatin-associated factors harbor multiple
known or predicted histone binding domains, both within a single protein, and within
distinct subunits of macromolecular complexes. This offers a diverse and exciting potential
for multivalent histone engagement [98] (Fig. 1) that adds a previously underappreciated
layer of specificity to histone PTM recognition. A number of closely spaced histone binding
domains within single proteins have been shown to coordinately engage histone PTM
signatures on a single histone tail, termed cis interactions [99–106]. A recent example is the
tandem Tudor domain (TTD) and PHD finger of UHRF1, which together, coordinate an
interaction with H3K9me3 and the N-terminus of an H3 tail, respectively [100, 107, 108].
Importantly, disrupting the reader function of either domain individually, or perturbing the
ability for this dual domain to engage the H3 tail in cis, was shown to inhibit the UHRF1
chromatin interaction and prevent UHRF1 from facilitating the epigenetic inheritance of
DNA methylation [104] (Fig.3).
Interestingly, crystal structures of the UHRF1 TTD-PHD bound to H31–11K9me3 revealed
that H3 residues lysine 4 through alanine 7 adopt a single turn of an α-helix [108]. Since the
H3 tail peptide in complex with the isolated PHD finger is in an extended conformation, it is
assumed that multivalent TTD-PHD engagement induces conformational change in the H3
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tail. It is notable that tail domains of histone proteins are rich in positively charged lysines
and arginines and lack detectable secondary structure when observed as nucleosomes, free
histones, and/or peptides. These findings have led to the perception that tail domains are
intrinsically disordered. However, classic studies from Grunstein and colleagues predicted
that regions within the H3 and H4 tails have the propensity to adopt amphipathic α-helices,
β-sheets, and β-turns [109]. More recent studies using advanced molecular modeling
algorithms have reached similar conclusions, suggesting that the H4 tail can form β-hairpins,
and the H3 and H2B tails may adopt α-helices [110, 111]. Interestingly, it appears that
PTMs may influence the departure from extended tail conformations, either directly by
stabilizing secondary structures [111] or indirectly (as described above with UHRF1)
through the recruitment of effector proteins that appear to induce conformational change in
histone tails [57, 100, 101]. Indeed, H31–13in complex with the double PHD finger of the
MOZ lysine acetyltransferase adopts an extensive α-helix, spanning H3 residues lysine 4
through threonine 11, and, unlike the helix adopted by UHRF1, several residues spanning
the helix make hydrogen bonds with MOZ [101]. This helical conformation, and effector
protein interaction, is maintained when lysines 9 or 14 are acetylated. Importantly, the acetyl
group on lysine 14 forms a hydrogen bond with the main chain amine of isoleucine 260 on
MOZ, and the proximity of this interaction appears to be facilitated by the helical turn.
The potential for histone PTMs to either induce or stabilize secondary structures suggests
that histone PTMs distant in sequence may in fact be in proximity for combinatorial
influence. This possibility adds an exciting new level of regulation that may underlie how
histone PTMs function. Future structural work will reveal the dynamics of induced
secondary structures upon effector protein binding, the propensity for other effector protein
interactions to induce conformational change in histone tails, and the direct effects (or lack-
there-of) on PTM-induced conformational change. It is important to note that these recent
instances of histone tails with stabilized secondary conformations were observed with
peptides. The propensity for histone tail structure in the physiological context of chromatin
may be more challenging, both energetically and physically. Furthermore, it will be
interesting to question whether effector proteins are able to recognize histone tails that have
already adopted secondary structure, or whether the ground state of histone tails is indeed
unstructured.
Multivalent interactions spanning adjacent histone tails within a single nucleosome or on
adjacent nucleosomes (Fig. 1), termed trans interactions, have been more difficult to study,
largely due to technological challenges in generating optimal templates for biophysical
assays. However, a number of recent studies provide compelling evidence for trans
interactions in chromatin [112–114]. The BPTF subunit of the NURF chromatin-remodeling
complex harbors a PHD finger adjacent to a bromodomain, a common reader domain
combination found in chromatin-associated proteins [98]. Biophysical studies using
modified histone peptides connected by rigid DNA linkers, as well as semi-synthetic mono-
and di-nucleosomes, demonstrated that PHD engagement of H3K4me3 and bromodomain
engagement of H4K16ac within a single nucleosome provided an optimal scaffold for BPTF
recruitment [114]. This important finding was supported by structural analysis, which
suggested that in nature, a rigid, helical linker connecting the domains provides the optimal
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spacing to facilitate this trans interaction. While disruption of either reader domain in BPTF
was demonstrated by chromatin immunoprecipitation (ChIP) to affect HOX gene targeting
of the NURF complex, in what way this multivalent trans interaction impacts NURF
chromatin remodeling function at these loci and others remains to be determined.
These and other recent studies have conveyed awareness that histone binding domains
within proteins and protein complexes are often functioning in a coordinate manner.
Notably, a number of paired histone binding domains characterized to engage the chromatin
template in a multivalent manner harbor single domain reader functions that are broadly
shared among chromatin-associated factors. For instance, the PHD finger of BPTF shares
the ability to read H3K4me3 with a growing list of chromatin-associated factors [33, 115–
117], and the TTD of UHRF1 is one of a host of identified H3K9me3 readers [57, 102, 118–
121]. Importantly, in vitro affinity measurements for these interactions are often similar,
suggesting the possibility that competition for histone PTMs exists at defined regions of
chromatin. It is intriguing to speculate that multivalency may in fact provide a mechanism to
circumvent this potential competition problem, as these dual interactions are often more
energetically favorable than single domain interactions [122]. Decoding the energetics and
interaction networks of paired or multidomain complexes will certainly be of fundamental
importance moving forward. Importantly, these studies indicate that it may be insufficient to
characterize isolated histone binding domains without taking into account the potential
function or influence of adjacent regions. In addition, the discovery of asymmetry within
histone tails in a single nucleosome [35] suggests that trans-tail interactions may be more
prevalent than initially thought. Technological advances, such as more straightforward
routes to facilitate the construction of defined semi-synthetic nucleosomes [123], will also
be needed to aid future discoveries of trans-tail histone interactions.
3. Emergence of a DNA methylation language
Classic studies have unquestionably shown that DNA sequence is a major driving force in
genome function through the direct recruitment of sequence-specific binding factors to
cognate DNA elements (Fig. 2). Perhaps the clearest examples lie in the control of gene
expression, where many landmark studies have identified an expanding list of activators and
repressors that target DNA elements to drive transcriptional states [124]. These studies have
also shaped our view of how the transcription regulatory machinery, via DNA binding,
regulates histone modification states and histone variant patterns [125]. In addition to DNA
sequence, it has become increasingly apparent that DNA modifications, much like histone
PTMs, can regulate the association and downstream functions of factors that directly bind
DNA (Fig. 2). High-resolution mapping of DNA modification patterns and systematic
characterization of factors that interact specifically with these marks are revealing important
new insights into how DNA modifications play an active role in chromatin regulation.
Below, we highlight recent advances in our understanding of DNA modifications and how
these marks integrate with histone modifications to create a diverse epigenetic landscape
that functions coordinately with the underlying DNA sequence to dynamically regulate
chromatin function.
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3.1. Reading DNA methylation
DNA methylation in eukaryotes, which occurs primarily at the 5-position of cytosine
residues (5mC) in the context of CpG dinucleotides (Table 2), is a heritable chromatin
modification long-studied for its key role in repressive chromatin regulatory processes like
X-chromosome inactivation, genomic imprinting, and retrotransposon silencing [13]. It is
estimated that 80% of all CpG sites in the genome are methylated, accounting for roughly
1% of the total nucleotide pool [126]. DNA methylation has classically been shown to
function in gene silencing through direct occlusion of the interaction of transcription factors
with DNA [127](Fig. 2) and by serving as a binding site for methyl-binding domain (MBD)
proteins often associated with chromatin remodelers and transcriptional co-repressor
complexes [13]. Methyl-CpG binding protein 2 (MeCP2) was the first MBD identified to
specifically read a symmetrically methylated CpG dinucleotide [128], and mutations in this
domain are causally linked to the X-linked neurodevelopmental disorder Rett Syndrome
[129, 130]. More recently, a second mutational cluster identified outside of the MBD
domain of MeCP2 [131] was shown to disrupt the interaction with the NCoR/SMRT co-
repressor complexes [132], suggesting a key role for MeCP2 as a bridging molecule
between 5mC and NCoR/SMRT. Subsequent members of the MBD family (MBD1-MBD4)
have been classified based on primary sequence similarity to the minimal region of MeCP2
required to bind symmetrically methylated DNA [128, 133]. Potential functional redundancy
of MBD1, MBD2, andMBD4, but not MBD3, is suggested from mouse knockout studies
[134–137]. Interestingly, MBD3 is unable to read methylated DNA due to two amino acid
substitutions in its MBD domain [138]. A recent study suggests this protein may in fact read
5-hydroxymethylcytosine (5hmC) [139], a proposed intermediate of oxidative DNA
demethylation [14] (see below). Genome-wide analysis demonstrated that MBD1, MBD2,
MBD4, and MeCP2 occupancy is directly proportional to CpG density [140]. However, in
vitro affinities for methylated CpG sites vary considerably among this protein family [141],
suggesting that other factors, such as additional known or putative chromatin-binding
domains within these proteins or unique interacting partners, may also contribute to their
cellular specificity.
Several other 5mC reader families have been recently identified, including a family of zinc
finger-containing proteins and SET and RING-associated (SRA) domain-containing
proteins. Kaiso, the flagship member of the zinc finger family, reads symmetrically modified
5mC (occurring on both DNA strands) in the context of tandem CpG dinucleotides [142].
Similar to MeCP2, Kaiso may be involved in the recruitment of the NCoR co-repressor
complex to mediate silencing of target loci [143]. Interestingly, Kaiso also reads with high
affinity a specific 5 base-pair unmethylated DNA sequence found at promoters of target
genes regulated by the Wnt signaling pathway [144, 145]. As structural analysis of Kaiso
binding to methylated and unmethylated DNA templates reveals similar molecular
interactions [146], a challenge for future study will be to determine the extent to which this
unique bimodal DNA recognition contributes to Kaiso-mediated gene regulation.
The SRA domain was first described as a bona-fide 5mC-binding motif in Arabidopsis
thaliana [147] and is restricted to the UHRF family of chromatin-interacting proteins in
mammals [148]. Evidence for an interaction of the UHRF1 SRA domain with hemi-
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methylated DNA was initially shown in crude nuclear extracts [149]. Structural studies
determined that the UHRF1 SRA domain binds hemi-methylated CpG sites [150–153],
similar to nucleotide-modifying enzymes [154, 155], by flipping the methyl-cytosine
nucleotide out of the DNA double helix into a cage-like hydrophobic pocket [150–153].
Importantly, this is the first example of a sequence-specific non-enzymatic DNA binding
domain to harbor base-flipping activity. Hemi-methylated CpG dinucleotides are a DNA
synthesis intermediate found at replication forks, and the faithful copying of the parental
DNA methylation pattern on the daughter strand by DNA methyltransferase 1 (DNMT1) is
central to the epigenetic inheritance model of DNA methylation [156, 157] (Fig.3). The
interaction of UHRF1 with both DNMT1 and hemi-methylated DNA suggests UHRF1 is
involved in this process [149, 158–160]. Indeed, deletion of Uhrf1 results in a pronounced
reduction in cellular DNA methylation levels [159, 160], and the SRA interaction with DNA
is required for DNMT1 chromatin targeting and subsequent DNA methylation maintenance
[161].
3.2. Breaking the dogma of DNA methylation silencing
Large-scale mass spectrometry-based screening approaches are revealing what appears to be
an expanded repertoire of proteins that read 5mC either directly or indirectly through
membership in macromolecular complexes [37, 162–164]. Paradoxical to the silencing
function of DNA methylation, a number of DNA-binding transcription factors, notably,
three Kruppel-like zinc fingers (KLF2, KLF4, and KLF5), bind specific DNA sequences in a
methylation-dependent manner [37, 165](Fig. 2). Interestingly, the Yamanaka
reprogramming factor KLF4 associates with both methylated and unmethylated DNA
binding motifs in cells, and biochemical studies suggest these non-competitive reading
activities are harbored in distinct domains of the protein [165]. Importantly, 5mC
recognition by KLF4 plays a stimulatory role in KLF4-mediated transcription. However, the
precise role of 5mC recognition in the stem-cell reprogramming function of KLF4 remains
to be determined.
Taken together, these intriguing findings expand the functional role of 5mC in gene
regulation, thus underscoring the potential for a DNA methylation language to regulate
active and repressive gene states in a site-specific manner. One of the most exciting concepts
to emerge from these studies is the realization that a methylated DNA sequence motif can
take on a new function by creating a novel DNA binding site for transcriptional activators
that could not be predicted from sequence information alone (Fig. 2). Thus, the complexity
of DNA modifications regulating genomic function is perhaps as complex now as
understanding the dynamics of histone PTM regulation. This complexity is further typified
by the recent findings that factors read the newly discovered oxidized derivatives of 5mC,
described further below.
3.3. Reading DNA hydroxymethylation and oxidized derivatives
Mechanisms facilitating the active removal of DNA methylation have been the subject of
much debate [14]. The recent discovery that the ten-eleven translocation (TET) family of
enzymes catalyze iterative 5mC oxidation to 5-hmC [166–168], 5-formylcytosine (5fC), and
5-carboxylcytosine (5caC) (the latter two being substrates for thymine DNA glycosylase-
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mediated base excision repair) [169, 170], significantly advanced our understanding of the
active DNA demethylation process. Importantly, recent identification of proteins that read
these oxidized derivatives of 5mC [37, 139, 171, 172] suggests that DNA-demethylation
independent functions of these DNA modifications may exist.
In addition to its interaction with 5mC, it has been demonstrated that UHRF1 can also read
5hmC [37, 171, 173]. While the significance of this interaction remains to be determined, it
was recently shown that the structurally homologous protein UHRF2 reads 5hmC and 5caC,
but not 5mC or 5fC [37]. Importantly, UHRF2 is unable to restore DNA methylation in cells
devoid of UHRF1 [174, 175], suggesting that while these two proteins share structural
identity, they may function in distinct biological pathways. Indeed, oxidative demethylation
by TET1 in HEK293T cells was enhanced in the presence of ectopically expressed UHRF2
[37]. Clearly, a relationship is emerging between the DNA demethylation pathway and
UHRF1/UHRF2, and future biochemical and biological studies are warranted to gain
mechanistic insight into how these discreet modifications to the cytosine ring are helping
orchestrate the complex recruitment and function of these factors.
Recent studies have also suggested that MBD proteins are capable of reading 5hmC [139,
172]. Interestingly, MBD3 localizes to hydroxymethylated gene promoters in a TET1-
dependent manner, and an identified physical interaction of MBD3 (unable to read 5mC; see
above) with 5hmC suggests TET1-mediated 5hmC may be a recruitment mechanism for
MBD3/NuRD-dependent gene regulation [139]. Additionally, MeCP2 was identified as a
reader of 5hmC [172], and a common mutation of MeCP2 found in Rett Syndrome [176]
disrupts the interaction with 5hmC while maintaining the ability of MeCP2 to read 5mC
[172]. The strong correlation between 5hmC and gene activation provides yet another
paradigm whereby a dual modification reader like MeCP2 may function as both a co-
activator and a co-repressor of transcription depending on the chromatin mark it reads.
Perhaps the most intriguing findings from the above studies are the wide range of potential
reader domains capable of interacting with the distinct methylation states on CpG
dinucleotides. This finding creates a new hierarchy of regulation and will lead to many
important studies into the functional significance of these interactions.
3.4. Reading unmodified CpG dinucleotides
While most CpG dinucleotides across the genome are methylated, repetitive clusters known
as CpG islands are found at more than half of transcriptionally active mammalian gene
promoters, and these islands are largely hypomethylated [177]. The identification of
cysteine-rich zinc-finger CxxC-containing proteins as readers of unmethylated CpG
dinucleotides suggests that CpG islands can play an active role in transcription [178].
Indeed, CxxC-finger protein 1 (CFP1), a subunit of the SET domain 1 (SETD1) H3K4
methyltransferase complex [179], associates with a large fraction of non-methylated CpG
sites in the mouse brain, most of which are also enriched for H3K4me3 [180]. Importantly,
integration of artificial CpG islands into promoter-free regions of the mouse genome is
sufficient to establish new H3K4me3 domains, suggesting a key role for CFP1 in directing
H3K4me3-dependent transcription.
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The presence of CxxC domains in TET1 and TET3, but not TET2, suggests unmethylated
CpG sites may constitute, at least in part, a targeting mechanism and nucleation point for
subsequent DNA demethylation. However, efforts to characterize the CxxC domains of
TET1 and TET3 as bona-fide CpG readers in vitro have been difficult, presumably due to
the positive charge of these domains promoting non-specific DNA interactions [181–184].
Interestingly, the CxxC domain of IDAX, an ancestral gene product of TET2, now
transcribed from a divergent promoter [185], is necessary to promote caspase-dependent
TET2 degradation [186]. TET3, through the action of its own CxxC domain, is also
regulated in a similar manner. These unexpected consequences of TET2 and TET3
chromatin recruitment are suggestive of interesting auto-regulatory loops to ensure the
maintenance of hypomethylated genomic states.
4. Coordinate function of histone and DNA modifications in chromatin
regulation
4.1. Multivalency in DNA and histone recognition
Significant insight into chromatin regulation has come from recent studies revealing that
DNA and histone modifications are functioning in a cooperative manner to re-shape
chromatin organization and facilitate the recruitment of effector proteins and their
macromolecular complexes to discreet locations throughout the genome. Significantly,
pioneering work of Kouzarides, Mann, and colleagues using a semi-synthetic
mononucleosome assembly strategy coupled with quantitative MS has begun defining an
interaction network of proteins and protein complexes that read both histone and DNA
modification states [163]. CpG methylated or unmethylated DNAs wrapped around
recombinant histone octamers containing uniformly modified H3K4me3, H3K9me3, or
H3K27me3 were used as baits to enrich for interacting proteins from HeLa nuclear extracts.
From these proteomic experiments, a rich list of factors whose interaction with chromatin
may be directed by modifications on both histones and DNA has emerged [163]. For
example, UHRF1 binding to H3K9me3-containing nucleosomes was enhanced by CpG
methylation, consistent with the identified functions of its TTD-PHD histone binding
module [104] and SRA domain [150–153]. In contrast, KDM2A binding to H3K9me3-
containing nucleosomes was perturbed by CpG methylation, consistent with the identified
function of its CxxC domain as a reader of unmethylated CpG dinucleotides [187].
Importantly, several protein complexes, including ORC and PRC2, were identified that
appear to read simultaneous modification states on both histones and DNA, likely through
distinct subunits. Indeed, the Mi-2/NuRD complex can sense methylated DNA through its
MBD2 subunit and unmodified H3 N-terminal tails through its CHD4 [112] and CHD5
subunits [113], and the repressive function of the MBD2/CHD4-containing NuRD complex
appears to be dependent on the coordinate function of these two interactions [188].
Another example of DNA and histone multivalency is the pre-initiation complex for
RNAPII transcription. Here, the largest multi-subunit complex, TFIID, harbors the TATA-
box binding protein (TBP) in addition to the TAF1 and TAF3 subunits that contain paired
bromodomains and a PHD finger, respectively. A landmark study by Tjian and colleagues in
2000 identified the bromodomains of TAF1 to be dual histone acetyllysine readers [32] –
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thus providing an expanded mechanism by which TFIID may be recruited and/or stabilized
at gene promoters. This mechanism may be particularly important in proper positioning of
TFIID at TATA-less promoters that do not utilize TBP. In addition to the TAF1 interaction
with histone acetylation, recent SILAC coupled with MS analysis revealed that the PHD
finger of TAF3 is a specific reader of H3K4me3 [189] – a mark found at the +1 nucleosome
along with H3/H4 acetylation. Significantly, recent studies have shown that TAF3
interaction with H3K4me3 is required for proper gene activation [190]. Taken together,
these data underscore the role of multivalent histone and DNA interactions in creating a
precise epigenetic signature that is read by the RNAPII transcription machinery.
4.2. Multivalency in the generation of defined epigenetic landscapes
Combinatorial DNA and histone modifications also contribute to the diversity of epigenetic
landscapes and chromatin states by influencing the generation and removal of distant marks.
Several recent examples of multivalent mechanisms underlying the creation of defined
chromatin signatures on histones and DNA are discussed below.
The Jumonji C (JmjC) domain-containing histone lysine demethylase KDM2A catalyzes the
removal of H3K36me2 [191]. The identified function of its CxxC domain as a reader of
unmethylated CpG dinucleotides [187] suggests that DNA recognition may be important for
cellular KDM2A catalytic activity. Indeed, this was shown to be the case [187], providing a
likely explanation for why CpG island promoters are devoid of H3K36me2. Likewise,
CxxC-mediated recognition of unmethylated CpG islands by SET1-associated CFP1 is
necessary to prevent the spread of H3K4me3 to distal regulatory elements [192].
Recent studies also demonstrate that the establishment, maintenance, and removal of DNA
methylation is intricately linked to the recognition of histone PTMs. Parental DNA
methylation patterns, largely erased between fertilization and the blastocyst stage, are re-
established during early embryogenesis by the de novo DNA methyltransferases DNMT3A
and DNMT3B (with the associated, but non-catalytic DNMT3L) [193], and are stably
maintained through somatic cell divisions [194] primarily by the maintenance
methyltransferase DNMT1 [195] (Fig. 3). Waves of DNA methylation reprogramming also
occur through germ cell development and carcinogenesis, recently reviewed elsewhere [196,
197]. DNMT3A, DNMT3B and DNMT3L share a cysteine-rich ADD domain, aptly named
for the four proteins identified to harbor this motif (ATRX-DNMT3A/B-DNMT3L), that
binds the unmodified N-terminus of histone H3 [198– 200]. Furthermore, in vitro catalysis
of DNA methylation by DNMT3A/DNMT3L on linker DNA of semi-synthetic nucleosomal
arrays was disrupted when nucleosomes harbored H3K4me2 or H3K4me3, suggesting a role
for the ADD domain in DNMT3A/DNMT3L recruitment [201] (Fig. 3). While these data
are consistent with the anti-correlative genome-wide distribution of DNA methylation and
H3K4me3, thebiologicalsignificance of these putative recruitment mechanisms remains to
be determined. Interestingly, DNMT3A and DNMT3B also harbor PWWP domains
essential for chromatin targeting in cells [202–204], and biochemical studies suggest the
PWWP domain of DNMT3A reads H3K36me3 [205]. Given that H3K36me3 is a histone
PTM associated with transcription elongation and is found within the bodies of RNAPII-
regulated genes, it has been speculated that DNMT3A/B contributes to gene-body DNA
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methylation that widely occurs but is poorly understood [206]. Indeed, it was recently shown
in mouse ESCs that DNMT3L is a positive regulator of gene body DNA methylation within
active genes [207]. Interestingly, this same study showed that a physical interaction between
DNMT3L and the EZH2 subunit of the PRC2 complex ensures that poised bivalent
promoters remain hypomethylated.
Unlike the de novo methyltransferases, mechanisms facilitating the recruitment of the
maintenance methyltransferase DNMT1 to chromatin have been somewhat elusive. A
replication foci targeting sequence (RFTS) facilitates the interaction of DNMT1 with
proliferating cell nuclear antigen (PCNA) at replication forks [208]. However, disruption of
this interaction has a minimal effect on cellular DNA methylation [209]. The identification
of a CxxC domain in DNMT1 that binds unmethylated CpG dinucleotides and is necessary
in cells for enzymatic function [210] suggests an interesting interplay between the ability of
DNMT1 to sense both unmethylated and hemi-methylated DNA, the latter of which appears
to be an inherent property of its catalytic domain [208, 211, 212]. Interestingly, recent
structural studies suggest that these unbound domains function as auto-regulators of
DNMT1 activity, as both an acidic loop C-terminal to the CxxC domain and the RFTS
domain limit catalytic function of the enzyme by inserting into the active site [213, 214].
Recent studies linking UHRF1 genetically and physically to DNMT1 chromatin targeting
and activity [150–153, 159, 160] strongly suggest that UHRF1 modulates DNMT1
chromatin function. Excitingly, it was recently shown that the UHRF1 RING domain has E3
ubiquitin ligase activity towards H3K23 [161]. H3K23 monoubiquitination was identified as
being read by DNMT1 in an RFTS-dependent manner, providing an unexpected mechanism
by which a histone modification facilitates DNA methylation maintenance (Fig. 3). This is
one of the few examples of how ubiquitination on a histone may be driving recruitment of a
chromatin modifier, and further, underscores the more general potential for how histone
monoubiquitination may serve as a binding platform, as is found for monoubiquitinated
proteins in cell signaling [215].
Aided by important technological advances in both sample collection and genome-wide
mapping capabilities, the dynamics of epigenetic reprogramming in the early stages of
development have been re-examined extensively over the past several years (for recent in-
depth reviews, see [193, 197]). Intriguingly, chromatin-templated mechanisms regulating
these impressive dynamics of DNA methylation during embryogenesis are being uncovered.
The time-scale in which DNA methylation is lost in the paternal and maternal nuclei
suggests that both active and passive removal mechanisms, respectively, are in place (Fig.
3). Indeed, recognition of H3K9me2 by the maternal factor PGC7 is necessary to protect
maternal 5mC from TET3-mediated oxidative demethylation [216, 217] (Fig. 3). Although
paternal nuclei also express PGC7, sperm DNA is packaged with protamines rather than
histones, and therefore lack the ability to recruit PGC7, resulting in active TET3. In
addition, Dnmt1 and Np95 (mouse UHRF1) are excluded from maternal nuclei and
primordial germ cells, accounting for the passive loss of DNA methylation in these cells
[197, 218]. Understanding the relationship between PGC7 and TET3, the structural basis for
PGC7 recognition of H3K9me2, and the signals controlling the subcellular localization of
Rothbart and Strahl Page 16






















Dnmt1 and Np95 at specific cell stages will be required to fully appreciate these key
developmental regulatory mechanisms.
5. Future challenges towards understanding chromatin regulation
Similar to histone PTMs, we are still just scratching the surface of understanding how key
players in the generation, removal, and interpretation of DNA modifications are regulated in
the context of the epigenetic landscape. To fully grasp the depth and breadth of complexity
underlying how histone and DNA modifications function together, many remaining
unanswered questions must be tested experimentally. A number of immediate future
challenges towards interpreting the complex epigenetic language are discussed below.
5.1. Determine the influence ofsequence context on the recognition of DNA modifications
Compared to histone residues, the sequence context surrounding CpG dinucleotides
throughout the genome is enormous. This diversity alone suggests the rules governing DNA
modification interactions will be more challenging to decipher than histone PTM
interactions. Indeed, several recent studies suggest that, similar to histone PTM recognition
and transcription factor binding, DNA readers have the ability to differentially sense the
sequence surrounding a modified CpG. For example, in the above-described semi-synthetic
nucleosome strategy for identifying dual readers of histone and DNA modifications, two
DNA sequences with similar nucleosome forming properties but differing sequences [219]
were used to assemble nucleosomes [163] for MS enrichment. Interestingly, factors were
identified that bound in a sequence-dependent and independent manner, suggesting that
some, but not all CpG readers are influenced by sequence context. Moreover, recent analysis
of transcription factor binding to 154 unique CpG methylated DNA sequences demonstrated
that most of these newly-identified CpG readers bound methylated DNA in a sequence-
dependent fashion [165]. Differing sequence preferences have also been documented for
several MBD proteins [220, 221], a property to consider when using these domains as
methylated CpG affinity enrichment tools. This poses intriguing questions regarding the
rules that dictate whether specific neighboring nucleotides (or combinations thereof) attract
or repel CpG readers. The already realized level of apparent sequence preference suggests
that there is minimal redundancy in the DNA modification language. Rather, in parallel to
the original postulate of the ‘histone code,’ CpG modifications at defined genomic locations
may also direct distinct biological outcomes.
5.2. Definethe structural families of DNA modification readers
Our understanding of functions associated with histone PTMs has been facilitated, in part,
by detailed structural and biochemical characterization of the protein domains that bind to
histone modifications [33, 34]. Undoubtedly, atomic resolution structural mapping of
binding interactions for newly identified DNA modification readers will facilitate our
understanding of how DNA modifications are read and interpreted. While a number of these
proteins harbor DNA binding domains commonly found in transcription factors, including
zinc fingers, homeoboxes, and helix-loop-helix domains [37, 165], it is likely that many
newly discovered DNA modification readers will engage their mark through novel motifs.
Excitingly, a number of identified DNA modification readers also harbor known or putative
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histone binding domains. For example, death inducer obliterator (DIDO) isoforms contain
PHD fingers shown to read H3K4me3 [116, 117, 163]. The recent identification of DIDO1
as a sequence-specific reader of CpG methylation [165] poses an interesting question
regarding the contributions of these DNA and histone reading activities to DIDO functions.
Indeed, determining how proteins interact with CpG modifications, as well as cytosine
modifications in other, lesser-studied, sequence contexts [222], will ultimately lead to a
deeper understanding of known and novel biological functions of these marks.
5.3. Complete the dictionary of chromatin modifications
Drawing the analogy of DNA and histone modifications being akin to letters of the alphabet,
we would be unable to form words and sentences like transcriptional activation or DNA
repair without first learning the identity of all of the letters in the alphabet as well as the
order in which to place them. Therefore, crucial to our future understanding of chromatin
function will be the identification of the full complement of DNA and histone modifications
and their combinations, as well as their precise locations throughout the genome.
While much of the PTM landscape on the N-termini of histones have been defined, we
surprisingly still know very little about the identity and combinations of PTMs present on
histone C-termini, globular domains, and variant histones. Indeed, important functions
associated with modifications to these less-studied regions of histones are continually
emerging. For example, Zhang and colleagues recently used an elegant combination of yeast
genetics and biochemistry to identify a conserved mechanism by which H3K56ac promotes
Rtt101-dependent ubiquitination of three lysines in the H3 C-terminal tail (K121, K122, and
K125) [223]. This ubiquitination promotes the necessary transfer of H3-H4 dimers between
the histone chaperones Asf1 and RTT106/CAF-1 for nucleosome assembly and reveals
novel crosstalk between the histone ubiquitination and acetylation machinery beyond
competition for the same residue.
Proteomic technologies are also advancing to the point where comprehensive analysis of all
core histones and their variants is now possible[36, 39, 42]. As new types of histone PTMs
will likely continue to be identified, a full understanding of epigenetic regulation will
require knowledge of how these PTMs function, and how they contribute antagonistically or
synergistically with known PTMs to regulate the distinct functions associated with them.
Likewise, the recent discovery of oxidized derivatives of CpG methylation suggests that the
dictionary of DNA modifications is also incomplete. For example, the existence of CpA,
CpT, and CpC methylation has been known for some time now [222], but it is unclear
whether these modifications are also susceptible to oxidative demethylation.
5.4. Define the modification landscape at individual genomic loci
Another significant set of challenges we face is to develop new technologies that enable
characterization of the PTM landscape at defined genomic loci and to determine how this
landscape contributes to the architecture and function at these regions, through specific cell
stages, cycles, and developmental contexts. From a practical standpoint, knowing this
information will be key to understanding of how deregulation of the epigenetic machinery
contributes to the re-wiring of the epigenetic landscape in human disease.
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Several recent studies have indeed begun addressing this challenge using distinct
approaches. Notably, Tackett and colleagues recently developed a technique they call
Chromatin Affinity Purification with Mass Spectrometry (ChAP-MS) that allows for
enrichment of native ~ 1 kilobase sections of chromatin for site-specific identification of
chromatin-associated proteins and histone PTMs [224]. While powerful, this technique
requires insertion of a LexA DNA binding site into the genomic region of interest for site-
specific targeting of the LexA protein, and is therefore limited to routine use in genetically
tractable systems. An important modification to this technique circumvents this problem by
using transcription activator-like (TAL) effector proteins as targeting molecules [225]. TALs
can easily be designed to target any ~ 20-nucleotide genomic locus of interest without
genetic manipulation, and are therefore a powerful tool for site-specific high-resolution
genomic targeting. This modified technique was used to define the chromatin architecture of
the GAL1 gene in Sacchromyces cerevisae, which was found to be enriched for a number of
single histone PTMs, including H3K14ac, H3K56ac, all three states of H3K79 methylation,
H2BK17ac, and H2AK7ac [225]. A number of di-acetyl histone PTM combinations were
also found at this locus. Furthermore, over 50 unique proteins were identified to reside at the
GAL1 gene, including a number previously identified transcriptional regulators like the
Spt16 subunit of the FACT transcription elongation complex and Gal3.
Recent studies have also begun defining with high-resolution the nucleosomal landscapes
occupied by chromatin-associated proteins in an unbiased manner [226, 227]. One notable
study coupled the powerful approaches of mononucleosome-resolution ChIP coupled with
next-generation DNA sequencing (Mnase-ChIP-seq), RNA sequencing, and MS to
simultaneously reveal 1) the combinations of histone PTMs associated with HP1 isoforms
and several members of the bromodomain and extraterminal family (BET), 2) the genomic
loci harboring these nucleosomes, and 3) the transcriptional state of these nucleosomes
[226]. BET family proteins (Brd2, Brd3, and Brd4) were enriched at active gene promoters
predominantly harboring H3K4me3 in combination with K9ac, K14ac, and K23ac, as well
as H4K5ac in combination with K12ac and K16ac. Gene bodies were also enriched for BET
family proteins, and histones in these regions were predominantly marked with H3K4me1 in
combination with K14ac, K23ac, and K79me1 as well as H4K8ac in combination with
K12ac, K16ac, and K20me1. Interestingly, a large number of gene promoters occupied by
BET family proteins were the key developmental HOX genes, although the functional
significance of this intriguing finding is not understood. Approaches like this are an
important step towards understanding how chromatin-associated proteins read and translate
the epigenetic language, and future studies incorporating DNA modification analyses will
give an even more complete picture of how histone and DNA modification states coordinate
functional outcomes in defined regions of chromatin.
5.5. Assign function to chromatin modifications
As we continue to discover new chromatin modifications, their combinations, genomic
locations, and protein readers, a key challenge moving forward is to define how any
particular modification, on DNA or histones, tips the balance towards distinct biological
outcomes. Our ability to now site-specifically modify the chromatin landscape in complex
eukaryotic systems using re-purposed genome editing tools like zinc-finger (ZF) nuclease,
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transcription activatorlike effector (TALE) nuclease, and clustered regulatory interspaced
short palindromic repeat (CRISPR) technologies [228–231] is an important step towards
tackling this central question. In addition, chemical-induced [56] and light-induced [232]
chromatin targeting approaches also allow the direct examination of the functional
consequences of DNA and histone modifications. For example, Crabtree and colleagues
elegantly adapted a chemical-induced proximity system for precision targeting of chromatin
modifiers [56], whereby stimulation by a bi-functional small molecule causes the rapid,
reversible association of two different peptide tags fused to proteins of interest in the cell.
They then engineered the mouse Oct4 promoter to harbor ZFHD1 and GAL4 DNA binding
sites in-frame with a GFP reporter. By tethering ZFHD1 to FKBP, and the chromoshadow
domain of HP1α (which directly interacts with the H3K9 methyltransferases SUV39h1/2
and SETDB1) to Frb, they were able to use rapamycin to promote an interaction between
FKBP and Frb, which resulted in the recruitment of HP1α and H3K9 methylation to the
engineered ZFHD1 binding site of Oct4. Excitingly, this resulted in a cascade of events,
including the spread of H3K9me3, the loss of H3K4me3, and the gradual increase in DNA
methylation that collectively created a new, stable domain of transcriptionally repressed
heterochromatin even in the absence of continued HP1α targeting. Importantly, they showed
that the kinetics of DNA methylation at this locus trailed the kinetics of H3K9 methylation
and discovered that the maintenance of the repressed domain in the absence of further HP1α
targeting was dependent on DNA methylation at this locus. Interestingly, by tethering the
transcriptional activator VP16 to PYL1, and GAL4 to ABI1, they were similarly able to
recruit VP16 to the GAL4 DNA binding site at this repressed Oct4 locus by addition of
abscisic acid, which resulted in reactivation of silenced GFP. This result suggests that robust
transcriptional activation can outcompete the signals of heterochromatin, and the authors
propose that DNA methylation at the Oct4 promoter may function to maintain this
heterochromatin domain by directly preventing the binding of transcription factors.
6. Concluding remarks
Progress over the past several decades has ushered in a new wave of appreciation for the
role of histone modifications in diverse chromatin functions. The complexity of histone
modifications in regards to the sheer number of identified PTMs, alone and in combination,
is astonishing in itself. The discovery of proteins harboring multiple reader domains that
interpret these combinatorial PTMs on histones to perform their chromatin functions
suggests our original one modification-one domain model underestimates the real situation
and complexity of histone function. The discovery of new protein families that read DNA
modification states and patterns of histone and DNA modification embedded in nucleosomes
places the ‘histone code’ within the framework of a much broader language of epigenetic
modifications. Taking into account known single PTMs on the four core histone tail
domains, occurring symmetrically or asymmetrically, in conjunction with the known single
modification states of CpG dinucleotides, regardless of DNA sequence context, would imply
the potential for an enormous number of unique chromatin signatures throughout the
genome. Even if only a fraction of these combinations contribute to biological functions of
chromatin, we will surely stay busy decoding the astonishing language of histone and DNA
modifications for years to come.
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• Histone PTMs and DNA modifications coordinately regulate chromatin function
• Newly revealed modifications add distinct elements of regulatory control on the
chromatin template
• Aided by new technologies, a newfound appreciation for the complexities of
DNA and histone recognition is emerging
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Figure 1. Writing, erasing, and reading the histone and DNA modification landscape
Isolated and linked protein domains coordinate the addition (writing), removal (erasing), and
association (reading) of DNA modifications (black circles) and histone PTMs (blue circles
and red triangles), creating a dynamic and variable chromatin environment. Cis refers to
multivalent events occurring on the same histone. Trans refers to multivalent events
occurring on adjacent histones or spanning histones and DNA, either within the same
nucleosome or on neighboring nucleosomes. Trans interactionswith distant nucleosomes
(which may be in 3-dimensional proximity) are not depicted. Multivalent interactions
facilitated by membership in macromolecular complexes are also not depicted.
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Figure 2. Coordinate genetic and epigenetic mechanisms regulate transcription factor binding
(Left) Transcription factor (TF) binding to cognate DNA sequence motifs (yellow box)
regulates transcriptional output (orange box). (Right) TF binding to methylated DNA
sequence motifs (black circles) both positively and negatively regulates transcriptional
output.
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Figure 3. Distinct combinatorial epigenetic modifications play key roles in the erasure,
establishment, and maintenance of DNA methylation patterns through organismal development
(Left) PGC7 protects the maternal genome from active DNA demethylation. PGC7 binding
to H3K9me2 (blue circles) protects maternal DNA methylation (black circles) from TET3-
dependent oxidative demethylation by an unknown mechanism. The paternal genome lacks
histones, and TET3 demethylation is therefore active in these cells. (Center) DNMT3A/B
and DNMT3L re-establish DNA methylation patterns in early development. DNMT3A/B
interacts with the H3 N-terminus through an ADD domain and H3K36me3 (blue circles)
through a PWWP domain. DNMT3L also interacts with the H3 N-terminus through an ADD
domain and physically associates with the methyltransferase domain of DNMT3A/B to
allosterically stimulate de novo DNA methyltransferase activity. (Right) UHRF1 facilitates
the DNMT1-mediated maintenance of established DNA methylation patterns through
embryonic and somatic cell divisions. UHRF1 physically associates with chromatin in a
trivalent manner through its TTD and PHD domains that engage a single histone H3 tail (cis
interaction) that is tri-methylated at lysine 9 (H3K9me3; blue circles) and unmodified at the
N-terminus, respectively, and through its SRA domain that engages hemi-methylated DNA
(black circles), a DNA replication intermediate. The UHRF1 RING domain aids in the
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catalysis of H3K23 ubiquitination (H3K23ub; green triangle), which serves as a binding
platform for DNMT1. DNMT1 also physically interacts with DNA (see text) and with the
SRA domain of UHRF1. Cartoon representations of nucleosomal interactions are depicted
based on biochemical and structural studies, but may not be accurate in regards to
orientation within the nucleosome.
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Table 1
Reading and interpreting histone post-translational modifications
Modification Type Structure Associated Functions Reader Domains
Lysine gene regulation PHD, ADD, WD40
mettiylation















ubiqurtination 8.5 kDa polypeptide, C-term Gly isopeptide bonded wiltiLys ε-amine
gene regulation DNA repair,
heterochromatin ?
sumoylation 11 kDa polypeptide, 2° structure similar to ub, C-termGly isopeptide bonded wilti Lys ε-amine gene regulation ?
ADP-ribosylation gene regulation DNA repair,DNA replication PAR
Arginine gene regulation PHD
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Modification Type Structure Associated Functions Reader Domains
methylation gene regulation Tudor, WD4D, ADD
citrullination gene regulation, chromatinstructure ?
Serine
phosphorylation gene regulation, DNA repair,mitosis BRCT, 14-3-3
acetylation ? ?




glycosylation β-N-acery1glucosarnine (O-GlcNAc) gene regulation ?
Tyrosine
phosphorylation gene regulation ?
acetylation ? ?
hydroxylation gene regulation ?
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Modification Type Structure Associated Functions Reader Domains
Histidine
phosphorylation gene regulation ?
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Table 2
Reading and interpreting DNA modifications
Modification Type Structure Associated Functions Reader Domains
Cytosine (CpG) gene regulation CxxC
methylaion (5mC) X-inactivation, imprinting, long-term silencing, development,gene regulation MBD, ZF, SRA (others?)
hydroxymethylation (5hmC) ? MBD, SRA (others?)
fomnylation (5fC) ? ?
caiboxylation (ScaC) ? SRA (others?)
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